Pregnancy in Childhood Cancer Survivors | Telehealth | Ovarian Cancer Treatment, 03/16/2022

National Cancer Institute

Having trouble viewing this email? View it as a Web page.

Bookmark and Share

Cancer Information Highlights
From the National Cancer Institute
Updating you about cancer causes, prevention, screening, treatment, coping, and more
 
New from NCI
Good News and Cautions about Pregnancy for Childhood Cancer Survivors
Mom and baby   As adults, survivors of childhood cancer are just as likely to have healthy babies as those without a history of cancer. But, they may have more health risks during pregnancy, which calls for more intensive care.

Telehealth illustration

 

Telehealth in Cancer Care Surged during COVID

Experts say we need to study how to best move telehealth from a temporary solution during the pandemic to a permanent part of cancer care. At the same time, experts worry that groups of people who could benefit the most may be left behind.

Ovarian tumor

 

Trametinib Is a New Treatment Option for Rare Form of Ovarian Cancer

New results from a large clinical trial provide the first strong evidence that a rare form of ovarian cancer, known as low-grade serous ovarian cancer, should be treated differently than other forms of the disease.

CAR T Cells: Engineering Immune Cells to Treat Cancer

Research to improve CAR T-cell therapy is progressing quickly. Researchers are working to expand its use to treat more types of cancer and to better understand and manage its side effects. Learn how CAR T-cell therapy works, which cancers it’s used to treat, and current research efforts.

NCI-COG Pediatric MATCH Precision Medicine Clinical Trial

After a brief pause, this research study is once again open and enrolling children, teens, and young adults with cancer. Learn about this trial that assigns young people to an experimental treatment based on the genetic changes found in their tumors rather than where the cancer is found in the body.

PDQ Updates

Hairy Cell Leukemia Treatment

Hairy cell leukemia is a rare, slow-growing cancer that starts in the bone marrow. Learn about the diagnosis and treatment of this cancer on our recently updated page.

 
Also of Interest

TMIST: Study Comparing Digital Mammograms (2-D) with Tomosynthesis Mammograms (3-D)

TMIST is a breast cancer screening study that will help researchers learn about the best way to find breast cancer in women who have no symptoms. This updated page describes who can enroll, how to enroll, what happens when you enroll, and the goals of the study.

COVID-19 Vaccines and People with Cancer

Are there some people with cancer who should not get a COVID-19 vaccine? Do COVID-19 vaccines make cancer treatment less effective? Can COVID-19 vaccines cause cancer? On this updated page, Dr. Steven Pergam of Fred Hutchinson Cancer Research Center answers these and other questions about COVID-19 vaccines.

Contact Us for Help

Information specialists at NCI’s Cancer Information Service (CIS), NCI's contact center, are available to help answer your cancer-related questions in English and Spanish. Reach us by phone, chat, or email.